Sio Capital Management as of Sept. 30, 2024
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 39 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Labcorp Holdings Com Shs (LH) | 15.4 | $39M | 173k | 223.48 | |
| Intuitive Surgical Com New Put Option (ISRG) | 11.5 | $29M | 59k | 491.27 | |
| Teva Pharmaceutical Industries Sponsored Ads (TEVA) | 9.6 | $24M | 1.3M | 18.02 | |
| Maximus (MMS) | 5.7 | $15M | 155k | 93.16 | |
| Zimmer Holdings (ZBH) | 5.5 | $14M | 128k | 107.95 | |
| Vaxart Com New (VXRT) | 4.6 | $12M | 14M | 0.85 | |
| Kenvue (KVUE) | 4.4 | $11M | 475k | 23.13 | |
| Teleflex Incorporated (TFX) | 3.9 | $9.7M | 39k | 247.32 | |
| Tyra Biosciences (TYRA) | 3.7 | $9.4M | 401k | 23.51 | |
| Disc Medicine (IRON) | 3.7 | $9.2M | 188k | 49.14 | |
| Cigna Corp (CI) | 3.6 | $9.2M | 27k | 346.44 | |
| Annexon (ANNX) | 3.4 | $8.5M | 1.4M | 5.92 | |
| Biodesix (BDSX) | 3.1 | $7.7M | 4.3M | 1.78 | |
| Relay Therapeutics (RLAY) | 2.7 | $6.7M | 946k | 7.08 | |
| Erasca (ERAS) | 2.4 | $6.1M | 2.2M | 2.73 | |
| Compass Pathways Sponsored Ads (CMPS) | 2.3 | $5.8M | 915k | 6.30 | |
| Astria Therapeutics (ATXS) | 2.2 | $5.6M | 505k | 11.01 | |
| Pmv Pharmaceuticals (PMVP) | 1.9 | $4.8M | 3.2M | 1.49 | |
| Ventyx Biosciences (VTYX) | 1.7 | $4.3M | 2.0M | 2.18 | |
| Ideaya Biosciences (IDYA) | 1.5 | $3.9M | 123k | 31.68 | |
| CryoLife (AORT) | 1.3 | $3.2M | 121k | 26.62 | |
| Cargo Therapeutics (CRGX) | 1.3 | $3.2M | 174k | 18.45 | |
| Context Therapeutics (CNTX) | 1.0 | $2.6M | 1.3M | 1.96 | |
| Enanta Pharmaceuticals (ENTA) | 0.7 | $1.8M | 177k | 10.36 | |
| Nuvation Bio Com Cl A (NUVB) | 0.6 | $1.5M | 668k | 2.29 | |
| Foghorn Therapeutics (FHTX) | 0.4 | $1.1M | 122k | 9.31 | |
| X4 Pharmaceuticals | 0.3 | $872k | 1.3M | 0.67 | |
| Aprea Therapeutics Com New (APRE) | 0.3 | $761k | 277k | 2.75 | |
| Avalo Therapeutics Com New (AVTX) | 0.3 | $679k | 72k | 9.50 | |
| Rapt Therapeutics | 0.3 | $633k | 315k | 2.01 | |
| Boundless Bio (BOLD) | 0.2 | $562k | 162k | 3.47 | |
| Nyxoah Sa SHS (NYXH) | 0.2 | $486k | 51k | 9.55 | |
| Verastem Com New (VSTM) | 0.2 | $399k | 133k | 2.99 | |
| Modular Med Com New (MODD) | 0.1 | $272k | 121k | 2.25 | |
| Nextcure (NXTC) | 0.1 | $178k | 130k | 1.37 | |
| Humacyte *w Exp 08/27/202 (HUMAW) | 0.0 | $89k | 50k | 1.78 | |
| Terns Pharmaceuticals (TERN) | 0.0 | $83k | 10k | 8.34 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $29k | 400k | 0.07 | |
| Caremax *w Exp 06/08/202 | 0.0 | $107.587200 | 13k | 0.01 |
